Cannabis Investors: Can Hexo (TSX:HEXO) Stock Make a Comeback in 2021?

Will Hexo’s (TSX:HEXO) strong cannabis-infused beverage sales help drive its stock price higher in 2021?

| More on:

Another year has gone by that sees cannabis stocks underperforming the broader markets by a huge margin. Shares of Hexo (TSX:HEXO)(NYSE:HEXO) are trading at $1.37, which meant it has lost close to a quarter of its market value in 2020. Hexo stock is also trading 87% below its all-time high price.

However, since the start of November, Hexo shares have risen 70% to trade at the current price. Does this mean it can gain momentum in 2021 and continue its upward spiral?

Is Hexo stock a buy?

Hexo is a Canada-based marijuana company and recently released its fiscal fourth-quarter results (ending in July). The company reported net revenue of $27.1 million, a growth of 76% year-over-year and 23% on a sequential basis.

This stellar performance was supported by its adult-use beverages segment that accounted for $2 million in sales, up from just $431,000 in the third quarter. Hexo’s non-beverage sales also gained pace and rose by 16% to $25.1 million.

Hexo announced a joint venture with Molson Coors back in 2018 in order to gain traction in Canada’s cannabis-infused beverage market. The joint venture, Truss, launched five new brands in 2020, offering consumers multiple beverage options.

However, similar to most peer companies, Hexo is also grappling with negative profit margins. In Q4, Hexo’s net loss stood at $169.5 million, up $18.8 million year-over-year. Hexo attributed the losses to goodwill impairments and inventory write-downs.

After accounting for non-cash items, investment gains, and other adjustments, Hexo’s EBITDA loss stands at $3.3 million. Alternatively, investors should also note that the company is struggling to sell its inventory which indicates a loss in market share or lower than estimated demand.

In Q4, Hexo produced 16,540 kilograms of dried cannabis but sold just 50% of its production. This trend has been visible for close to five quarters where Hexo has consistently sold less cannabis compared to the amount it harvested. We can see why Hexo is struggling with lackluster demand and massive asset write-downs.

A major driver for Hexo stock

Marijuana stocks have gained pace in the last month after Joe Biden won the presidential race. During one of the pre-election debates, Vice President-elect Kamala Harris said the Democrats would decriminalize the use of marijuana at the federal level, which drove the pot market rally.

The legalization of cannabis south of the border will be one of the major drivers of Hexo’s stock price. This legalization may take a few years to materialize which suggests Hexo should focus on gaining market share and reducing losses in the Canadian market.

Hexo stock has a market cap of $660 million, which means its trading at a forward price to sales multiple of 4.96. Analysts also expect the company’s earnings loss to narrow from $1.77 per share in fiscal 2020 to $0.03 in fiscal 2022.

Comparatively, its sales are forecast to grow by 65% to $133.5 million in 2021 and by 30% to $173 million in 2022. We can see that Hexo is reasonably valued, especially if it can improve the bottom line and remain consistently profitable.

The Motley Fool recommends HEXO. and HEXO. Fool contributor Aditya Raghunath has no position in any of the stocks mentioned.

More on Cannabis Stocks

four people hold happy emoji masks
Dividend Stocks

Wary of Mining Companies? A Lower-Risk Way to Get in on the Gold and Silver Surge

Frenco-Nevada (TSX:FNV) stock might be a wiser way to play the run in gold prices this year.

Read more »

Cannabis smoke
Cannabis Stocks

Have Cannabis Stocks Totally Gone Up in Smoke?

Let's dive into whether Canadian cannabis stocks are still investable, and what investors should make of the recent volatility in…

Read more »

Researcher works in hemp field
Cannabis Stocks

1 Undervalued Cannabis Stock to Buy and Hold Over the Next Decade

Green Thumb is a beaten-down cannabis stock that trades at a compelling valuation in September 2025.

Read more »

Researcher works in hemp field
Cannabis Stocks

Pot Stocks Rallied Hard in August: Is There More to Come?

Tilray Brands (TSX:TLRY) and the broad basket of pot stocks could heat up from here.

Read more »

Pot stocks are a riskier investment
Cannabis Stocks

Canopy Growth Stock Jumped 30% Last Month: What’s Going on?

Canopy Growth (TSX:WEED) stock is picking up traction again, making it an enticing weed play to buy on strength.

Read more »

A cannabis plant grows.
Cannabis Stocks

These Threats Facing Canopy Growth Stock Could Justify Selling it

Let's dive into whether Canopy Growth (TSX:WEED) is a top stock investors should buy right now after its recent dip…

Read more »

A person holds a small glass jar of marijuana.
Stocks for Beginners

This BioCannabis Firm Could Explode with Product Approval

This cannabis stock used to be a major name, so where does it stand now?

Read more »

Medicinal research is conducted on cannabis.
Stocks for Beginners

This TSX Health-Care Stock Is a Long-Term Buy for Patient Investors

This TSX stock continues to be one of the best long-term opportunities, if you're patient.

Read more »